Outsmarting the Heart at ISHLT 2025 At our ISHLT 2025 symposium, a multi-disciplinary faculty discussed unmet needs with guideline directed medical... Read More
Device Therapy Targeting the Neurohormonal Pathway in Heart Failure Patients Barostim is a novel device therapy that works with guideline-directed medical therapy and targets the... Read More
Integrating Barostim into a Comprehensive Heart Failure Program at ISHLT 2024 Did you miss our symposium at ISHLT 2024? Watch the recordings to hear an expert faculty panel featuring Drs.... Read More
Baroreflex Activation Therapy for HFrEF Patients: Long-Term Data and Real-World Experience at ESC 2023 Read More
Key Insights from the BeAT-HF Trial at DGK Mannheim 2023 At DGK Mannheim 2023, Dr. Michael Zile presented the results of the BeAT-HF study. The trial evaluated the safety,... Read More
